Fetuin-A / Alpha-2-HS Glycoprotein (AHSG)

Class hepatokine / metabolic signaling glycoproteinReceptor TLR4-associated signaling interactions and metabolic receptor pathways

Function

Fetuin-A, also known as alpha-2-HS glycoprotein, is a liver-derived peptide signaling hormone involved in mineral balance, insulin signaling modulation, inflammatory communication, and regulation of calcification pathways. The hormone functions as an important circulating glycoprotein that helps prevent inappropriate mineral deposition within soft tissues and blood vessels.

Fetuin-A contributes to calcium-phosphate transport, extracellular mineral buffering, adipose tissue communication, metabolic signaling, and regulation of inflammatory adaptation. The hormone also participates in communication between liver metabolism, vascular tissues, skeletal physiology, and endocrine nutrient-regulation systems. Through these actions, it supports coordinated mineral and metabolic homeostasis.

Production

Fetuin-A is produced primarily by hepatocytes within the liver. Additional expression may occur in adipose tissue and additional metabolic organs under certain physiological conditions. The hormone is synthesized as a glycoprotein secreted directly into circulation where it interacts with mineral complexes and metabolic signaling pathways.

Production reflects integration between hepatic metabolism, inflammatory signaling, nutrient status, and mineral-related physiological demand. Circulating concentrations are influenced by both metabolic and inflammatory conditions.

Regulation

Fetuin-A production is regulated by inflammatory cytokines, hepatic metabolic signaling, calcium-phosphate balance, insulin-related pathways, oxidative stress systems, and nutrient availability. Liver physiology and inflammatory adaptation strongly influence secretion dynamics.

The hormone acts through interactions with mineral complexes, insulin-signaling pathways, toll-like receptor-associated systems, and extracellular matrix signaling mechanisms. Fetuin-A influences vascular calcification pathways, adipose communication, and metabolic adaptation through integrated endocrine and inflammatory signaling systems. Through these coordinated regulatory pathways, fetuin-A supports mineral homeostasis, metabolic signaling, vascular protection, and extracellular calcium regulation.

Identity & Secretion

Primary Source GlandLiver hepatocytes

Secretion PatternMetabolic and liver-derived endocrine signaling

Half-life2400 min

PrecursorAHSG glycoprotein precursor

Nutrient Requirements

Nutrient Precursors

amino acids, protein synthesis substrates

Required Vitamins

vitamin-b6,vitamin-b9,vitamin-c

Required Minerals

zinc,magnesium,selenium,phosphorus

Key Foods

broccoli,kale,spinach,garlic,blueberry,pomegranate,green-tea-brewed,turmeric-ground,oats-cooked,brown-rice-cooked

Targets & Signaling

Target Tissues

Liver, adipose tissue, skeletal muscle, pancreas, endothelial tissue, immune cells, tumor microenvironment

Feedback Loops

Fetuin-A signaling influences TLR4-mediated inflammatory signaling, insulin resistance pathways, NF-kB activation, adipokine signaling, metabolic stress responses, and feedback loops involving obesity, fatty liver biology, and inflammatory cytokines.

Second Messengers

TLR4,NF-kB,PI3K,AKT,AMPK,mTORC1,STAT3

Pathways Involved

insulin-signaling,pi3k-akt-pathway,nfkb-pathway,ampk-signaling,mtorc1-signaling,immune-response,oxidative-phosphorylation

Key Functions

Metabolic regulation, insulin signaling modulation, calcification control, adipose communication, inflammatory signaling, fatty liver signaling, endothelial interactions.

Plant-Based Focus

Whole-food plant-based patterns rich in legumes, whole grains, cruciferous vegetables, berries, leafy greens, mushrooms, and high-fiber foods provide phytochemicals studied for modulation of insulin signaling, oxidative stress, inflammatory pathways, endothelial biology, and metabolic inflammation.

Clinical Context

Normal RangeApproximately 300-1000

Unitsmcg/mL

Assay Notes
Fetuin-A is measured mainly in metabolic, cardiovascular, obesity, NAFLD, diabetes, and inflammatory research settings and is often interpreted with insulin resistance markers and inflammatory cytokines.

Linked Knowledge

Phytochemicals

quercetin,egcg,curcumin,sulforaphane,resveratrol,chlorogenic-acid,ellagic-acid

Amino Acids

arginine,glutamine,glycine,cysteine,serine

Foods

broccoli,kale,spinach,garlic,blueberry,pomegranate,green-tea-brewed,turmeric-ground,oats-cooked,brown-rice-cooked

Vitamins

vitamin-b6,vitamin-b9,vitamin-c,vitamin-e

Minerals

magnesium,zinc,selenium,phosphorus,manganese

Cancers (context)

Liver Cancer,Colorectal Cancer,Breast Cancer,Pancreatic Cancer,Prostate Cancer,Endometrial Cancer

Ailments

Insulin Resistance,NAFLD,Metabolic Syndrome,Type 2 Diabetes,Chronic Inflammation,Endothelial Dysfunction

Dietary Modulators

Whole grains, legumes, cruciferous vegetables, berries, mushrooms, leafy greens, green tea, and high-fiber plant foods

Inhibitors / Activators

Inhibitors

quercetin,egcg,curcumin,sulforaphane,resveratrol

Activators

Obesity-associated inflammation, insulin resistance, fatty liver signaling, TLR4 activation, oxidative stress, inflammatory cytokines

Summary

Fetuin-A is a liver-derived metabolic signaling protein associated with insulin resistance, chronic inflammation, endothelial dysfunction, fatty liver biology, and obesity-related tumor microenvironments. Elevated Fetuin-A signaling is linked with metabolic inflammation and cancer-associated metabolic dysregulation.

SUMMARY OF EFFECTS ON THE BODY

Fetuin-A participates in metabolic communication and calcification regulation, while elevated Fetuin-A activity is associated with chronic inflammatory signaling, insulin resistance, endothelial dysfunction, obesity-linked metabolic stress, and pro-tumor metabolic environments.

Research

Fetuin-A, also called AHSG, is a hepatokine strongly associated with insulin resistance, metabolic syndrome, obesity-related inflammation, NAFLD, endothelial dysfunction, and inflammatory metabolic signaling. Fetuin-A interacts with TLR4-related inflammatory pathways and has been studied in obesity-associated cancer biology, metabolic inflammation, and insulin signaling disruption.